Armenia vs Kiribati: The number of people with susceptibility test result for rifampicin
Armenia
209
in 2021
Kiribati
177
in 2021
Armenia rank
93rd
Kiribati rank
96th
The number of people with susceptibility test result for rifampicin over time
- Armenia
- Kiribati
How they compare
Armenia currently reports 209 against 177 in Kiribati, a difference of 32.
That makes Armenia's figure about 1.2 times Kiribati's.
Across all 5 years both countries report, Armenia has been ahead every year.
Armenia ranks 93rd and Kiribati ranks 96th of 155 countries.
Armenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 267.67 | 115.67 | 152 | Armenia |
| 2020s | 203.5 | 175.5 | 28 | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Armenia or Kiribati?
- Armenia, at 209 against 177 in Kiribati as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Armenia and Kiribati?
- 32, with Armenia ahead.
- How many years of comparable data are there for Armenia and Kiribati?
- 5 years are reported by both, from 2017 to 2021.
- How do Armenia and Kiribati rank globally for the number of people with susceptibility test result for rifampicin?
- Armenia ranks 93rd and Kiribati ranks 96th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.